Functional validation of putative toxin-antitoxin genes from the Gram-positive pathogen Streptococcus pneumoniae: phd-doc is the fourth bona-fide operon by Wai Ting Chan et al.
ORIGINAL RESEARCH ARTICLE
published: 05 December 2014
doi: 10.3389/fmicb.2014.00677
Functional validation of putative toxin-antitoxin genes from
the Gram-positive pathogen Streptococcus pneumoniae:
phd-doc is the fourth bona-fide operon
Wai Ting Chan1*, Chew Chieng Yeo2, Ewa Sadowy3 and Manuel Espinosa1
1 Molecular Microbiology and Infection Biology, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain
2 Faculty of Medicine and Health Sciences, Universiti Sultan Zainal Abidin, Kuala Terengganu, Terengganu, Malaysia
3 Department of Molecular Microbiology, National Medicines Institute, Warsaw, Poland
Edited by:
John R. Battista, Louisiana State
University, USA
Reviewed by:
Tatiana Venkova-Canova, The
University of Texas Medical Branch
at Galveston, USA
Ramon Diaz Orejas, Consejo
Superior de Investigaciones
Científicas, Spain
*Correspondence:
Wai Ting Chan, Centro de
Investigaciones Biológicas, Consejo
Superior de Investigaciones
Científicas, Ramiro de Maeztu 9,
28040 Madrid, Spain
e-mail: chanyting@hotmail.com
Bacterial toxin-antitoxin (TAs) loci usually consist of two genes organized as an operon,
where their products are bound together and inert under normal conditions. However,
under stressful circumstances the antitoxin, which is more labile, will be degraded more
rapidly, thereby unleashing its cognate toxin to act on the cell. This, in turn, causes cell
stasis or cell death, depending on the type of TAs and/or time of toxin exposure. Previously
based on in silico analyses, we proposed that Streptococcus pneumoniae, a pathogenic
Gram-positive bacterium, may harbor between 4 and 10 putative TA loci depending on
the strains. Here we have chosen the pneumococcal strain Hungary19A-6 which contains
all possible 10 TA loci. In addition to the three well-characterized operons, namely relBE2,
yefM-yoeB, and pezAT, we show here the functionality of a fourth operon that encodes the
pneumococcal equivalent of the phd-doc TA. Transcriptional fusions with gene encoding
Green Fluorescent Protein showed that the promoter was slightly repressed by the Phd
antitoxin, and exhibited almost background values when both Phd-Doc were expressed
together. These findings demonstrate that phd-doc shows the negative self-regulatory
features typical for an authentic TA. Further, we also show that the previously proposed
TAs XreA-Ant and Bro-XreB, although they exhibit a genetic organization resembling those
of typical TAs, did not appear to confer a functional behavior corresponding to bona fide
TAs. In addition, we have also discovered new interesting bioinformatics results for the
known pneumococcal TAs RelBE2 and PezAT. A global analysis of the four identified
toxins-antitoxins in the pneumococcal genomes (PezAT, RelBE2, YefM-YoeB, and Phd-Doc)
showed that RelBE2 and Phd-Doc are the most conserved ones. Further, there was
good correlation among TA types, clonal complexes and sequence types in the 48
pneumococcal strains analyzed.
Keywords: Streptococcus pneumoniae, pneumococcal toxin-antitoxin loci, Phd-Doc, Green Fluorescent Protein,
self-regulation
INTRODUCTION
Toxins-antitoxins (TAs) were discovered in the early 1980s and,
later on, their cellular function was extensively studied especially
in the past two decades. However, until now the world of TAs is
still perplexing. TAs are found abundantly in prokaryotes, espe-
cially in free-living bacteria, as well as in archaea, and probably
in fungi but so far, not in other eukaryotes (Pandey and Gerdes,
2005). In general, a TA locus consists of two genes organized as
an operon, with the antitoxin gene, which is generally precedes
the toxin gene, encoding either an untranslated RNA or a labile
protein that neutralizes the toxicity of its cognate toxin, whereas
Abbreviations: TAs, toxins-antitoxins; SD, Shine-Dalgarno; ant, antirepressor; bro,
baculovirus repeated orfs; GFP, Green Fluorescent Protein; OD, optical density;
STs, sequence types; ICEs, integrative and conjugative elements; MLST, multilo-
cus sequence typing; CCs, clonal complexes; Fic, filamentation induced by cyclic
AMP.
the toxin gene encodes a toxin protein that binds to the cellular
targets and halts essential cell processes. Under certain circum-
stances such as stress, the system would be triggered by a rapid
degradation of the antitoxin, thus liberating the toxin to act on its
target. Most known toxins function as RNases (Christensen et al.,
2001; Nariya and Inouye, 2008; Jørgensen et al., 2009; Yamaguchi
and Inouye, 2009), whereas other toxins target essential cellular
components such as DNA gyrase (Van Melderen, 2002), cell wall
(Mutschler et al., 2011), and EF-Tu elongation factor (Castro-Roa
et al., 2013). TAs have been classified into five types, depending
on how the antitoxin counteracts the toxin. Type II TAs, in which
the antitoxin is a protein that binds avidly to the toxin protein to
form an inert complex, are the most widely studied (Makarova
et al., 2009; Leplae et al., 2011). When found on plasmids, TAs
function primarily in the stable maintenance of the plasmid,
post-segregationally killing off any plasmid-free daughter cells
that developed. The functions of the chromosomally-encoded
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bacterial TAs are still intriguing. They might not be essential, but
they have been reported to be involved in a variety of cellular pro-
cesses related to global stress responses (Christensen et al., 2001),
programmed cell death (Engelberg-Kulka and Glaser, 1999),
maintenance of mobilomes (Rowe-Magnus et al., 2003; Szekeres
et al., 2007), persistence (Gerdes andMaisonneuve, 2012), biofilm
formation (Harrison et al., 2009; Soo and Wood, 2013), niche
colonization (Norton and Mulvey, 2012), virulence (Ren et al.,
2012), phage abortive infection system (Fineran et al., 2009; Dy
et al., 2014), and other important cellular processes (Goeders and
Van Melderen, 2014). Some bacterial genomes are bountiful in
TAs, e.g., Mycobacterium tuberculosis encodes 30 functional TAs
(Ramage et al., 2009), which makes their intricacy bewildering.
The ability of TAs to impart growth control may attribute to
the slow growth and dormant state, which are the hallmarks of
latent tuberculosis infection (Schifano and Woychik, 2014), but
the mechanisms involved, and how many TAs may be responsi-
ble for these phenotypic traits are still unknown. It is still unclear
whether the TAs within the same host could cross-talk. However,
some studies have shown that expression of one TAmight activate
another (Garcia-Pino et al., 2008). Whether numerous TAs would
provide cumulative or synergistic effect to the cells is something
worth to ponder.
Streptococcus pneumoniae (the pneumococcus) is a Gram-
positive bacterium, pathogenic for humans and responsible for
both infections in respiratory tracts as well as invasive infections,
and associated with significant morbidity and mortality (Chan
et al., 2012). Furthermore, clinical isolates of pneumococci show
a high degree of variability, probably due to the recombinogenic
nature of this bacterium (Claverys et al., 2006; Baquero, 2009).
We had previously identified up to 10 putative Type II pneumo-
coccal TAs based on in silico data mining (Chan et al., 2012), and
three of them had already been proven to be functional, namely
relBE2, yefM-yoeB, and pezAT (Chan et al., 2013). Here, we have
undertaken the validation and characterization of the rest of the
putative pneumococcal TAs.We show that S. pneumoniae encodes
a fourth functional TA operon, phd-doc, which corresponds to a
bona fide TA. Further, we experimentally ruled out some of the
predicted pneumococcal gene pairs as typical TAs, since some of
these putative toxins turned out to be either non-toxic, or possibly
toxic but lacking a cognate antitoxin gene.
MATERIALS AND METHODS
BACTERIAL STRAINS AND GROWTH CONDITIONS
S. pneumoniaeR6 (Hoskins et al., 2001) and Escherichia coliTop10
[F¯mcrA(mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1
araD139 (araAleu)7697 galUgalKrpsL(Strr) endA1 nupG] were
used as homologous and heterologous hosts for verification of
putative TAs from S. pneumonia Hungary19A-6 (McGee et al.,
2001) via overexpression assays. S. pneumoniae R6 was grown in
AGCH medium (Lacks, 1968) with 0.3 sucrose and 0.2% yeast
extract at 37◦C in static water bath, and supplemented with ery-
thromycin (1µg/ml) or tetracycline (1µg/ml) when the cells har-
bored recombinant plasmids pLS1ROM-MCS (Lacks et al., 1986;
Ruiz-Masó et al., 2012), or pAST (Ruiz-Cruz et al., 2010), respec-
tively. E. coli cultures were grown in TY medium (Sambrook
and Russel, 2001), at 37◦C with agitation at 250 rpm (for liquid
medium), and supplemented with kanamycin (50µg/ml) when
the cells harbored plasmid pFUS2 (Lemonnier et al., 2003) or its
derivatives.
DNA MANIPULATIONS, SEQUENCING, AND SEQUENCE DATA
ANALYSIS
DNA manipulations and other molecular biology techniques
were done following standard protocols (Sambrook and Russel,
2001). S. pneumoniae genomic DNA was extracted using the
Bacterial Genomic DNA Isolation Kit (Norgen Biotech Corp.).
Plasmid DNA from both S. pneumoniae and E. coli was iso-
lated using the High Pure Plasmid Isolation kit (Roche).
However, for S. pneumoniae, the plasmid extraction protocols
were slightly modified as described (Ruiz-Cruz et al., 2010).
DNA fragments and PCR products were purified with the
NZYGelpure from NZYTech. DNA was sent for automated
Sanger sequencing in Secugen S.L., Centro de Investigaciones
Biológicas, CSIC, Madrid. DNA sequences were analyzed using
the BioEdit Sequence Alignment Editor version 7.0.4.1 (Hall,
1999).
CONSTRUCTION OF RECOMBINANT PLASMIDS WITH S. PNEUMONIAE
HUNGARY19A-6 PUTATIVE TAs
All plasmids and primers used in this study are shown in Table 1,
and the details are described below.
pLS1ROM-MCS derivatives
Seven putative pneumococcal TA genes from strain Hungary19A-6
(GI: 169832377) (Chan et al., 2012) were verified in the S. pneu-
moniae homologous host. Plasmid pLS1ROM-MCS (Lacks et al.,
1986; Ruiz-Masó et al., 2012), which was derived from the
streptococcal promiscuous plasmid pMV158 (Espinosa, 2013),
harbors a tight maltose-inducible promoter PM. The pneumo-
coccal putative toxin genes along with their Shine-Dalgano (SD)
sequences were cloned downstream of promoter PM, and then
transformed (Lacks, 1968) into S. pneumoniae R6 for over-
expression assays. The seven putative toxin genes were: relE1
(GI: 169832900), hicA (GI: 169834067), genes COG2856CA (GI:
169832377 and 169833989), gene COG2856B (GI: 169832735),
doc (GI: 169833045), ant (antirepressor) (GI: 169833276; previ-
ously known as bro1, Chan et al., 2012) and bro (baculovirus
repeated orfs) (GI: 169834001; previously known as bro2, Chan
et al., 2012). In the case of the doc gene, its SD sequences were not
apparent and thus we decided to use the SD sequences of its cog-
nate antitoxin phd. Consequently, those which exhibited toxicity
to the cells, i.e., doc, ant and bro, were further analyzed by cloning
their cognate putative antitoxins phd (GI: 169832994), xreA (GI:
169832832; previously known as xre, Chan et al., 2012) and xreB
(GI: 169834410; previously known as xre, Chan et al., 2012), as
well as both putative TA operons along with their SD, respec-
tively, into pLS1ROM-MCS, and then subjected to overexpression
assays.
pFUS2SD and derivatives
The arabinose-inducible plasmid pFUS2 (Lemonnier et al., 2003)
was used to construct recombinant plasmids with the seven
putative toxins from S. pneumoniae Hungary19A-6 (as described
above) to validate their functionality in E. coli heterologous host.
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Table 1 | Recombinant plasmids used in this study.
Plasmids Descriptions and primers used
pFUS2, (Lemonnier et al., 2003) A 4.5 kb vector with ori-pBR322 which harbors an arabinose-inducible PBAD promoter upstream of a multiple
cloning site
pFUS2SD An SD consensus ′AGGAGG′ was inserted downstream of PBAD promoter and upstream of EcoRI restriction
site of pFUS2 plasmid. This recombinant plasmid was used for the cloning of putative toxins from
S. pneumoniae Hungary19A-6 and subsequently for overexpression assays in E. coli Top10
Forward primer: 5′-GGGCTAGCGAATTCGAGCTC-3′
Reverse primer: 5′-GATCGAATTCCCTCCTGCTAGCCCAAAAAAACGG-3′
pFUS2SD_YoeB pFUS2SD with yoeB from S. pneumoniae R6; as positive control in overexpression assays in E. coli Top10
Forward primer: 5′-GATAGAATTCATGCTACTCAAGTTTACAGA-3′
Reverse primer: 5′-GACAAAGCTTTTAGTAATGATCTTTAAAGG-3′
pFUS2SD_RelE1 pFUS2SD with relE1 from S. pneumoniae Hungary19A-6
Forward primer: 5′-AGTAGAATTCGTGCTTAAGATTCGTTATCA-3′
Reverse primer: 5′-TCATAAGCTTTTAAAATAAATCACTGTGAC-3′
pFUS2SD_HicA pFUS2SD with hicA from S. pneumoniae Hungary19A-6
Forward primer: 5′-AGTAGAATTCATGCCTATGACACAAAAAGA-3′
Reverse primer: 5′-TCATAAGCTTGCAGGGGCTGAATTTTACAA-3′
pFUS2SD_COG2856CA pFUS2SD with COG2856CA gene from S. pneumoniae Hungary19A-6
Forward primer: 5′-AGTAGAATTCATGGATTTAAGTAATAAAGC-3′
Reverse primer: 5′-TTGTAAGCTTTTATCCTAATGACATTTCCT-3′
pFUS2SD_COG2856B pFUS2SD with COG2856B gene from S. pneumoniae Hungary19A-6
Forward primer: 5′-AGTAGAATTCATGACTGAAAAAGAATTTTC-3′
Reverse primer: 5′-TCATAAGCTTTTAATTAAGTAGTGCTAAAT-3′
pFUS2SD_Ant pFUS2SD with ant from S. pneumoniae Hungary19A-6
Forward primer: 5′-AGTAGAATTCATGAACGAACTCATCAACGT-3′
Reverse primer: 5′-TCATAAGCTTCTAATTAAGGAACTTATCGA-3′
pFUS2SD_Bro pFUS2SD with bro from S. pneumoniae Hungary19A-6
Forward primer: 5′-AGTAGAATTCATGAACGAAATTTTTAATTT-3′
Reverse primer: 5′-TCATAAGCTTCTACCCTTCGTCAAATGAGT-3′
pLS1ROM-MCS, (Lacks et al., 1986;
Ruiz-Masó et al., 2012)
A 6.8 k vector derived from plasmid pLS1 that harbors a maltose-inducible PM promoter upstream of a
multiple cloning site. This plasmid was used for the cloning of putative TAs from S. pneumoniae
Hungary19A-6 and subsequently for overexpression assays in S. pneumoniae R6
pLS1ROM_HicA pLS1ROM-MCS with xreA from S. pneumoniae Hungary19A-6
Forward primer: 5′-AGTAAAGCTTGGTGTTGTCAGGAGGTAAAA-3′
Reverse primer: 5′-AGTCACTAGTGAATTTTACAACCCAGCTTG-3′
pLS1ROM_RelE1 pLS1ROM-MCS with xreA from S. pneumoniae Hungary19A-6
Forward primer: 5′-GTAGAAGCTTATTTGATGGAGGACTTACG-3′
Reverse primer: 5′-AGTCACTAGTGAGAACCCCCTTAAAATAGA-3′
pLS1ROM_COG2856CA pLS1ROM-MCS with xreA from S. pneumoniae Hungary19A-6
Forward primer: 5′-GTAGAAGCTTGGAAAAAGGTGAAAGGAATA-3′
Reverse primer: 5′-AGTCACTAGTTTCCTCATACTTCCCTTGCG-3′
pLS1ROM_COG2856B pLS1ROM-MCS with xreA from S. pneumoniae Hungary19A-6
Forward primer: 5′-GTACAAGCTTAGAAAGCAATAATAATAAAA-3′
Reverse primer: 5′-AGTCACTAGTTTTTCTCTCCTTTTTTAATT-3′
pLS1ROM_XreA pLS1ROM-MCS with xreA from S. pneumoniae Hungary19A-6
Forward primer: 5′-GATCCCAAGCTTCTATTATTTGTCAATGAATA-3′
Reverse primer: 5′-GATCCCACTAGTTTATTCCTCCAGCAATTGTT-3′
pLS1ROM_Ant pLS1ROM-MCS with ant from S. pneumoniae Hungary19A-6
Forward primer: 5′-GATCCCAAGCTTTTCAATTGCAAATTATTTAA-3′
Reverse primer: 5′-GATCCCACTAGTCTAATTAAGGAACTTATCGA-3′
pLS1ROM_XreA-Ant pLS1ROM-MCS with xreA-ant from S. pneumoniae Hungary19A-6
Forward primer: 5′-GATCCCAAGCTTCTATTATTTGTCAATGAATA-3′
Reverse primer: 5′-GATCCCACTAGTCTAATTAAGGAACTTATCGA-3′
pLS1ROM_XreB pLS1ROM-MCS with xreB from S. pneumoniae Hungary19A-6
Forward primer: 5′-GATCCCAAGCTTAGCACTAATACCAAGATGAA-3′
Reverse primer: 5′-GATCCCACTAGTTTATATTTGATTAGAGAGCC-3′
(Continued)
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Table 1 | Continued
Plasmids Descriptions and primers used
pLS1ROM_Bro pLS1ROM-MCS with bro from S. pneumoniae Hungary19A-6
Forward primer: 5′-GATCCCAAGCTTACACGATTATTCACCCCTTG-3′
Reverse primer: 5′-GATCCCACTAGTCTACCCTTCGTCAAATGAGT-3′
pLS1ROM_Bro-XreB pLS1ROM-MCS with bro-xreB from S. pneumoniae Hungary19A-6
Forward primer: 5′-GATCCCAAGCTTACACGATTATTCACCCCTTG-3′
Reverse primer: 5′-GATCCCACTAGTTTATATTTGATTAGAGAGCC-3′
pLS1ROM_Phd pLS1ROM-MCS with phd from S. pneumoniae Hungary19A-6
Forward primer: 5′-GAGCGGCCGCAGGAGGAAATCAGATGGTAGTAAAAACAAGAAA-3′
Reverse primer: 5′-CAGCGGATCCTCATTTTTCCACCAAAGCTT-3′
pLS1ROM_Doc pLS1ROM-MCS with doc from S. pneumoniae Hungary19A-6
Forward primer: 5′-GAGCGGCCGCAGGAGGAAATCAGATGACAATCTATTTGACAGA-3′
Reverse primer: 5′-CAGCGGATCCTTACTTTTTGACCTTTTCTC-3′
pLS1ROM_Phd-Doc pLS1ROM-MCS with phd-doc from S. pneumoniae Hungary19A-6
Forward primer: 5′-GAGCGGCCGCAGGAGGAAATCAGATGGTAGTAAAAACAAGAAA-3′
Reverse primer: 5′-CAGCGGATCCTTACTTTTTGACCTTTTCTC-3′
pAST, (Ruiz-Cruz et al., 2010) A 5.5 kb vector derived from plasmid pMV158 that harbors a multiple cloning site between the E. coli
T1T2rrnB terminator region and the promoter-less gfp gene
pAST_P A 231 bp of DNA encompassing the putative promoter of phd-doc from S. pneumoniae Hungary19A-6 was
inserted upstream of the gfp gene of pAST plasmid.
Forward primer: 5′-CAGAGGATCCCTGTTGGAAATGTAGCGTAC-3′
Reverse primer: 5′-CAGCGAGCTCCTGATTTCCTCCTTTGAAGT-3′
pAST_PPhd A 471 bp of DNA encompassing the putative promoter of phd-doc and phd gene from S. pneumoniae
Hungary19A-6 was inserted upstream of the gfp gene of pAST plasmid.
Forward primer: 5′-CAGAGGATCCCTGTTGGAAATGTAGCGTAC-3′
Reverse primer: 5′-CAGCGAGCTCTTGTCATTTTTCCACCAAAG-3′
pAST_PPhd An 878 bp of DNA encompassing the putative promoter of phd-doc and phd-doc genes from S. pneumoniae
Hungary19A-6 was inserted upstream of the gfp gene of pAST plasmid.
Forward primer: 5′-CAGAGGATCCCTGTTGGAAATGTAGCGTAC-3′
Reverse primer: 5′-CAGCGAGCTCTTACTTTTTGACCTTTTCTC-3′
The underlined sequences were the restriction sites used for cloning.
Since TA operons are usually co-transcribed and some of the toxin
genes which are located downstream of the antitoxin genes do
not have an obvious SD sequence, we had constructed plasmid
pFUS2SD (this study) by inserting an SD consensus sequence
(AGGAGG) downstream of the arabinose-inducible PBAD pro-
moter of pFUS2 by reverse PCR and then self-ligation. This
recombinant plasmid was subsequently used for the cloning of
the seven putative toxin genes fromHungary19A-6 strain. In addi-
tion, the known toxin yoeB (GI: 15903627) from S. pneumoniae
R6 was also constructed in pFUS2SD to serve as a positive con-
trol (Chan et al., 2011). All these genes were inserted at the EcoRI
restriction site downstream of the SD sequence, and thus the start
codons of all these genes were 6 bp apart from the SD sequence.
The recombinant plasmids were transformed into E. coli Top10
(Sambrook and Russel, 2001) and used to conduct overexpression
assays.
pAST derivatives
To verify the promoter activities and to characterize the tran-
scriptional regulation of the promoter by pneumococcal Phd and
Phd-Doc, transcriptional fusions were constructed to measure
Green Fluorescent Protein (GFP) fluorescence. Plasmid pAST
(Ruiz-Cruz et al., 2010), which harbors a promoter-less gfp gene
was used for this study. The putative promoter of the phd-doc
operon, the phd gene along with its promoter and the phd-
doc genes along with their promoter were inserted upstream
of the gfp gene of pAST plasmid, respectively. All the recom-
binant plasmids were transformed into S. pneumoniae R6 and
then to evaluate the promoter activities by measuring GFP
fluorescence.
OVEREXPRESSION ASSAYS OF PUTATIVE TAs IN S. PNEUMONIAE AND
E. COLI
Cell cultures of S. pneumoniae R6 harboring the different recom-
binant plasmids were grown in AGCH medium supplemented
with 0.3 sucrose and 0.2% yeast extract (Lacks et al., 1986) until
optical density (OD)650∼0.3 and subsequently subcultured to
OD650 of ∼0.02 in the same medium but with addition of 0.2%
maltose to induce promoter PM. OD of the cultures was mea-
sured every hour for 8 h. E. coli Top10 with different recombinant
plasmids were inoculated in TY medium (Maniatis et al., 1982)
supplemented with 0.4% glucose to repress expression from the
PBAD promoter, and the cells were allowed to grow until OD600
of ∼0.3. Cells were harvested and washed twice with TY medium,
followed by suspension in TY medium to OD600 of ∼0.02, and
then induced with 0.4% arabinose. The assays were repeated
three times and the mean values and the standard errors were
calculated.
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GFP FLUORESCENCE ASSAYS
To characterize the promoter activities of pneumococcal phd-doc,
fluorescence assays were conducted as previously described (Ruiz-
Cruz et al., 2010). Briefly, S. pneumoniae carrying recombinant
plasmids with various gfp-fusions were grown until OD650 ∼0.3.
Various volumes of cells (25µl to 1ml) were harvested and resus-
pended in 200µl 1 × PBS buffer in a 96-well black plate, respec-
tively. Fluorescence was measured with a Varioskan Flash Spectral
Scanning Multimode Reader (Thermoscientific) by excitation at
488 nm with a bandwidth of 12 nm and detection of emission at
515 nm. Three independent cultures were analyzed and results of
1ml of cultures were chosen to show in this manuscript. The cells
were also subsequently used for microscopy examination.
CELL MORPHOLOGY EXAMINATION WITH PHASE-CONTRAST AND
FLUORESCENCE MICROSCOPY
Cells from overexpression assays were harvested at 4 h and 8 h
after induction. Cells were washed twice with 1 × PBS, resus-
pended in 4% paraformaldehyde and fixed at room temperature
for 30min. Cells were again washed once with 1× PBS buffer and
resuspended in the same buffer. The fixed cells were placed on
polylysine coated microscope slides, air-dried and mounted with
Vectashield (Vector Laboratories) before being covered with cover
slides, and sealed with nail polish. The cells were examined under
microscope (Olympus CKX41), and pictures were taken at 100 ×
magnification. To examine pneumococcal cells harboring various
gpf -fused promoter-phd-doc recombinant plasmids, 10µl of cells
in 1 × PBS buffer from Section GFP Fluorescence Assays were
viewed under the phase-contrast and fluorescence microscopy.
Pictures were taken at 100 × magnification, 200ms.
BIOINFORMATICS ANALYSES
Genome databases in NCBI (http://www.ncbi.nlm.nih.gov/) and
Pfam (http://pfam.sanger.ac.uk/) were used for bioinformat-
ics analyses. Sequence alignments were conducted using web
tool Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/)
and the BioEdit Sequence Alignment analytical software,
whereas neighbor-joining phylogenetic trees were generated with
Composition Vector Tree Version 2 (http://tlife.fudan.edu.cn/
cvtree/) and MEGA6.05. A web-based resource for bacterial inte-
grative and conjugative elements (ICEs) termed ICEberg (http://
db-mml.sjtu.edu.cn/ICEberg/) (Bi et al., 2012) was used to detect
the presence of TAs in pneumococal ICEs. PHAST (PHAge
Search Tool) (http://phast.wishartlab.com/) (Zhou et al., 2011)
was used to identify TAs in prophage sequences within pneu-
mococcal genomes. In the case of strains, whose sequence types
(STs) were not directly available, sequences of seven loci used
in the multilocus sequence typing (MLST) scheme (Enright and
Spratt, 1998) were retrieved from genomic data and submitted
to the online database http://pubmlst.org/spneumoniae/ (28th
August 2014, date last accessed) to obtain allele numbers and
STs. Position of the STs was then analyzed for all strains within
the population snapshot, constructed based on the content of
the whole MLST database (28th August 2014, date last accessed)
using the eBURST approach (Feil et al., 2004) at http://eburst.
mlst.net/ and resulting clonal complexes (CCs) were named based
on the predicted founder of the group. The largest observed CC,
including ST156 as a proposed primary founder, was additionally
divided into lineages named according to the predicted secondary
founders.
RESULTS AND DISCUSSION
VERIFICATION OF THE PUTATIVE TAs FROM S. PNEUMONIAE
HUNGARY19A-6 IN S. PNEUMONIAE R6 AND IN E. COLI TOP10
Between 4 and 10 putative TAs were found in our previous
in silico analysis of S. pneumoniae genomes (Chan et al., 2012).
Genes of the putative TAs analyzed here were derived from the
Hungary19A-6 strain. It is a pathogenic strain, which harbors
all 10 putative TA pairs, thus covering most (if not all) of the
putative pneumococcal TAs reported to date. Three out of the
10 TA operons, namely the R6 strain relBE2, yefM-yoeB and
pezAT, had been previously shown to encode functional TAs
in S. pneumoniae and also in E. coli (Nieto et al., 2006, 2007;
Khoo et al., 2007). Thus, these three pairs were not included
here, with the exception of the yoeB toxin gene that was used
as a positive control for the overexpression assays in the E. coli
host.
The functionality of the seven putative toxins was first analyzed
in their natural host S. pneumoniae and the ones that retarded
cell growth were further analyzed with their cognate antitoxins.
In the case of the pneumococcal doc gene, the construction of
plasmid pLS1ROM-MCS harboring doc had a mutation at the
SD in which ′AGGAGG′ was changed to ′AGGCGG′. However,
this mutation did not hinder Doc protein to exhibit its toxic-
ity to the cell. Overproduction of Doc had strongly retarded the
growth of S. pneumoniae despite the growth resumed after 6 h
(Figure 1A). Nonetheless, its toxicity could be clearly neutralized
by co-expression of its cognate antitoxin Phd in cis (Figure 1B).
This finding demonstrated that the pneumococcal phd-doc pair
constitutes a bona fide functional TA. For Ant and Bro, cell growth
was also inhibited when the proteins were overproduced, respec-
tively, albeit less toxic than Doc (Figure 1A). Growth of S. pneu-
moniae cells resumed after a few hours of induction of the toxins
(Figure 1A), indicating the toxicity was temporal. Unexpectedly,
co-expression of their presumptive cognate antitoxins XreA and
XreB did not neutralize the toxicity of Ant and Bro, respectively
(Figure 1B). Expression of XreA and XreB alone was not toxic
to the cells, but intriguingly, the pairs XreA-Ant and Bro-XreB
seemed to be slightly more toxic to the cells, compared to the
Ant and Bro toxins alone (Figure 1B). Conversely, overproduc-
tion of the rest of the putative pneumococcal toxins HicA, RelE1,
COG2856CA, and COG2856B had no effect on the growth of
S. pneumoniae (Figure 1A).
In the case of the heterologous host E. coli, as in their native
host S. pneumoniae, overexpression of HicA, RelE1, COG2856CA,
and COG2856B were inert to the cells (Figure 1C). We were
unable to obtain the recombinant plasmid of pFUS2SD with the
putative pneumococcal toxin doc gene, most likely because of its
high toxicity to the host. As it was observed for YoeB, overexpres-
sion of the Ant and Bro proteins led to suppression of the growth
of E. coli; moreover, in contrast to S. pneumoniae, no indication
that the cultures resumed growth was found even after 8 h of incu-
bation, indicating that both proteins were very toxic to the host
(Figure 1C).
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FIGURE 1 | Overexpression of pneumococcal putative TAs.
(A) Overexpression of pneumococcal putative toxins in homologous host
S. pneumoniae had shown that HicA, RelE1, COG2856CA, and COG2856C
were not harmful to the cells; whereas overexpression of Doc, Ant and Bro
had thwarted cell growth but resumed a few hours albeit slowly. (B) Since
Doc, Ant and Bro were toxic to the cells, they were thus further analyzed to
ensure if their putative cognate antitoxins were functional as well in
S. pneumoniae host. For Doc, co-expression of its cognate antitoxin Phd
in cis had neutralized the Doc toxicity to the cell, signifying Phd-Doc is a
functional TA. On the other hand, overexpression of Ant and Bro repressed
the growth of the cells but co-expression of their cognate putative antitoxins
XreA and XreB, respectively, were not able to neutralize the toxic effect of the
toxins, and instead more toxic to the cells. Note that XreA or XreB alone was
inert to the cells. Thus, we have ruled out that XreA-Ant and Bro-XreB are
typical TAs. (C) Overexpression assays in heterologous host E. coli. Similar to
the natural host S. pneumoniae, overexpression of pneumococcal putative
toxins HicA, RelE1, COG2856CA, and COG2856C did not affect cell growth.
Unfortunately we were not able to construct doc toxin in pFUS2SD plasmid
likely due to its high toxicity. YoeB from strain R6, which is a known functional
pneumococcal toxin (Nieto et al., 2007; Chan et al., 2011) was used as a
positive control (pFUS2SD_YoeB), whereas pFUS2SD without insert served
as a negative control. As with the pneumococcal YoeB toxin, overexpression
of pneumococcal Ant and Bro inhibited growth of E. coli and no recovery was
observed even after 8 h of incubation, which was in contrary to the results in
S. pneumoniae, in which cell growth was resumed a few hours after toxins
overproduction.
We conclude that out of the seven gene pairs that we had inves-
tigated here, only Phd-Doc was demonstrated to be a bona fide
pneumococcal TA. Concerning Ant and Bro, overexpression of
each of these proteins inhibited growth of both S. pneumoniae
and E. coli; however, the products of their adjacent genes XreA
and XreB were unable to counteract their toxicity, respectively.
Therefore, we do not classify them as typical TA pairs. Thus, we
have re-evaluated the number of functional bona fide TAs for the
48 pneumococcal strains whose genomic sequences are available
in the NCBI genome databases (Table 2, see below).
THE PNEUMOCOCCAL PHD-DOC: THE FOURTH FUNCTIONAL TA PAIR IN
S. PNEUMONIAE
As mentioned above, the pneumococcal Doc was shown to be
toxic to its natural host, and co-expression of the cognate Phd
antitoxin was able to counteract the toxicity of Doc. The pneu-
mococcal phd-doc gene pair was present in a single copy in almost
all the genomes of pneumococcal strains examined (43 out of
48 strains; Table 2) (Chan et al., 2012). The phd-doc genes are
structured as an operon, which was consistently surrounded by
genes encoding Type I restriction-modification systems; further,
a gene that encodes a putative integrase/recombinase was also
conserved downstream of doc (Figure 2A). However, the genomic
context of phd-doc was not entirely conserved since, in some
strains, transposases were also evident further downstream. The
pneumococcal phd antitoxin and doc toxin genes overlap by four
nucleotides and both genes are likely co-transcribed from a sin-
gle promoter located upstream of phd (Figure 2A). An inverted
repeat of 8 nt (GTAA·TTAC) was identified, which partly covered
the −35 consensus sequences (Figure 2A). This differs from the
promoter of phd-doc of bacteriophage P1, in which two palin-
drome sequences (TGTGT·ACACA and CGAGT·ACACG) were
found to be located between the −10 consensus sequence and
the start codon of Phd, with one of the palindromes overlapping
the SD (Magnuson et al., 1996). We postulate that the inverted
repeat would function as the operator where the pneumococcal
Phd antitoxin binds to repress its own transcription, as in other
TAs (Magnuson et al., 1996; Tian et al., 2001; Kedzierska et al.,
2007). To test the regulation of transcription of pneumococcal
Phd-Doc, we constructed a set of pneumococcal plasmids based
on the pAST promoter-probe vector that harbors the gfp gene
(Ruiz-Cruz et al., 2010). Thus, transcriptional fusions allowed us
to measure the phd-doc promoter. In addition, and to demon-
strate whether Phd antitoxin and the Phd-Doc pair regulate their
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Table 2 | Distribution of sequence types, clonal complexes, and functional TAs in S. pneumonia.
Strain (N = 48) Sequence type Clonal complex Phd-Doc YefM-YoeB PezAT RelBE2a(type) Total
INV200 9 15 1 1 1 1 (II) 4
BS397 13 15 1 1 1 1 (II) 4
BS455 2011 15 1 1 1 1 (II) 4
BS457 13 15 1 1 1 1 (II) 4
BS458 13 15 1 1 1 1 (II) 4
SP-BS293 13 15 1 1 1 1 (II) 4
SP14-BS292 13 15 1 1 1 1 (II) 4
CGSP14 15 15 1 1 2 1 (II) 5
AP200 62 62 1 1 1 (II) 3
MLV-016 62 62 1 1 1 (II) 3
SP11-BS70 62 62 1 1 1 (II) 3
G54 63 63 1 1 (II) 2
JJA 66 66 1 1 1 2 (II & V) 5
ATCC 700669 81 81 1 2 2 (II&V) 5
670-6B 90 90 1 1 1 1 (II) 4
GA41317 2705 100 1 1 (II) 2
OXC141 180 180 1 1 1 (II) 3
SP3-BS71 180 180 1 1 1 (II) 3
CDC1087-00 191 191 1 1 1 (II) 3
CDC3059-06 199 199 1 1 2 (I&V) 4
TIGR4 205 205 1 1 1 1 (I) 4
P1031 303 217 1 2 2 (II&VI) 5
CDC0288-04 220 218 1 1 1 (IV) 3
GA41301 242 242 1 1 1 2 (II&V) 5
70585 289 289 1 1 1 (II) 3
INV104 227 306 1 b 1 (II) 2
GA47901 304 306 1 1 (II) 2
GA04375 236 320 1 1 (IV) 2
Taiwan19F-14 236 320 1 1 (IV) 2
str. Canada MDR_19A 320 320 1 1 (II) 2
str. Canada MDR_19F 320 320 1 1c 2
TCH8431/19A 320 320 1 1 (IV) 2
SP19-BS75 485 395 1 1 1 1 (II) 4
SP23-BS72 37 439 1 1 1 (II) 3
SP6-BS73 460 460 1 1 1 (I) 3
GA17545 9057 1536 1 1 (II) 2
CDC1873-00 376 2090 1 1 1 2 (II&V) 5
GA47368 1339 2090 1 1 1 2 (II&V) 5
CCRI 1974 124 L_124 1 1 (II) 2
CCRI 1974M2 124 L_124 1 1 (II) 2
SP14-BS69 124 L_124 1 1 1 (II) 3
SP18-BS74 146 L_146 1 1 (II) 2
GA17570 156 L_156 1 1 1 1 (III) 4
SP195 156 L_156 1 1 1 1 (III) 4
SP9-BS68 1269 L_162 1 1 1 1 (III) 4
Hungary 19A-6 268 L_176 1 1 1 1 (II) 4
D39 595 singleton 1 1 1 (I) 3
R6 595 singleton 1 1 1 (I) 3
aThe organization types (I–VI) of the RelBE2-TA are indicated within parenthesis.
bThere is a stop codon within YoeB (only 15 amino acid residues are translated) of strain INV104, and thus YefM-YoeB of this strain was excluded in this table.
cData not available for analyses.
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FIGURE 2 | Gene organization and expression of the pneumococcal
phd-doc locus. (A) The pneumococcal phd-doc is surrounded by genes that
encode Type I restriction-modification (RM) proteins and
integrase/recombinase. The pneumococcal phd antitoxin gene is located
upstream of its cognate toxin gene doc, and both genes overlap by 4
nucleotides. A promoter and a Shine-Dalgano (SD) were identified upstream
of phd, and an inverted repeat (denoted by arrows) was found overlapping the
−35 sequences (boxed); the −10 region of the putative promoter and the SD
sequences are also boxed. The stop codon of Phd is underlined and the start
codon of Doc is indicated in overline. (B) Expression and self-regulation of the
phd-doc operon. Cultures (1ml) of S. pneumoniae R6 cells harboring
recombinant plasmids were grown until an OD650 ∼0.3. Cells were
harvested, resuspended in 1 × PBS buffer and their fluorescence was
measured. Plasmids used were: pAST_P, harboring only the promoter of the
operon; pAST_PPhd, harboring the promoter and the phd gene;
pAST_PPhdDoc, harboring the entire phd-doc operon, and the promoter-less
gfp plasmid vector, pAST, used as control. SE (average of three independent
experiments) are indicated. (C) Cells examination under phase-contrast and
fluorescence microscopy. The GFP level for cells harboring pAST_P (a) and
pAST_PPhd (b) did not show much difference; whereas GFP level for
pAST_PPhdDoc (c) was visibly lower, which is coincided with the fluorescence
measurement. Cells harboring plasmid pAST served as negative control.
transcription, either the antitoxin or the TA pair was fused to
the promoter-less gene encoding GFP. Measurement of the levels
of fluorescence showed that indeed the promoter region resulted
in GFP expression of ∼8 arbitrary units, which were slightly
repressed by synthesis of the antitoxin (∼6 arbitrary units) and
repressed further to ∼1 arbitrary units (down to nearly basal
levels ∼0.1 arbitrary units) by the joint production of the Phd-
Doc pair (Figure 2B). In agreement to these results, observation
of these cells under phase-contrast and fluorescence microscopy
also demonstrated that the fluorescence was not much different
for cells harboring promoter-gfp and promoter-phd-gfp; whereas
the fluorescence of cells harboring promoter-phd-doc-gfpwas vis-
ibly lower (Figure 2C). Employment of the GFP reporter to detect
TA activation was previously shown for the Salmonella sehAB
operon (De La Cruz et al., 2013). In our case, it has turned
out to be a simple and reliable way to show auto-repression of
the phd-doc operon. Further, it could be used for any of the
TA to be tested and also to perform in vivo studies on condi-
tions that trigger any particular TA. To our understanding, this is
the first time that this strategy is performed for a Gram-positive
bacterium.
Like other Doc homologs, the pneumococcal Doc has a Fic
(filamentation induced by cyclic AMP) domain (Utsumi et al.,
1982) at the N-terminal moiety. In general, the conserved Fic
motif, HxFx(D/E)GNGRxxR (Engel et al., 2012; Goepfert et al.,
2013), possesses adenylylation (or “AMPylation”) activity (Itzen
et al., 2011; Woolery et al., 2012). By comparison, the consensus
residues of the Fic motifs in all Doc toxins are slightly different,
HxFx(D/N)(A/G)NKR (Cruz et al., 2014), as is the pneumococ-
cal Fic motif HVFANANKR. The target of the Doc toxin from
bacteriophage P1 (Magnuson and Yarmolinksy, 1998) was revised
recently, in which Doc was reported to be a new type of protein
kinase [instead of AMPylating like other Fic proteins (Kinch et al.,
2009) or obstructing ribosomes (Liu et al., 2008)] that inhibits
bacterial translation by phosphorylating the conserved threonine
(Thr382) of the translation elongation factor EF-Tu, thereby ren-
dering it unable to bind aminoacylated tRNAs (Castro-Roa et al.,
2013; Cruz et al., 2014). Interestingly, it was also demonstrated
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that the Phd antitoxin can only block the de novo phosphorylation
of EF-Tu, but cannot revert it, and dephosphorylation of EF-Tu
was probably catalyzed by the Doc toxin itself (Castro-Roa et al.,
2013). This finding coincided with our observation, in which the
inhibition of growth mediated by the pneumococcal Doc toxin
was slowly relieved a few hours after overexpression (Figure 1B).
It had been shown that ectopic overexpression of Doc in E. coli
might lead to Lon-dependent activation of RelE to exhibit its
mRNA cleavage activity (Garcia-Pino et al., 2008). Since S. pneu-
moniae harbors both RelBE and Phd-Doc TAs, it would be inter-
esting to find out whether both TAs could cross-talk as described
by Garcia-Pino et al. (2008).
MORPHOLOGY OF E. COLI AND S. PNEUMONIAE CELLS AFTER TOXIN
OVEREXPRESSION
In many cases where overexpressed genes may cause a toxic effect,
the bacterial cells change their morphology and may exhibit a
phenotype of either filamentation or other gross changes in the
cell shape (Scott et al., 2010). To test whether overexpression of
the various toxins analyzed here had any influence on the cell
morphology of S. pneumoniae and E. coli, cultures were subjected
to toxin overexpression under the above conditions, and cells were
observed using phase-contrast microscopy. In the case of S. pneu-
moniae no prominent morphological changes were observed for
any cells that overexpressed the different toxins (Supplementary
Figure S1). On the other hand, for E. coli, filamentation was
observed when Ant or Bro were overexpressed, indicating that the
cells were not dividing properly and thus cell growth was impaired
(Figures 3C,D). The filamentation was not reversible for at least
8 h as inhibition of cell growth by Ant or Bro did not show
any sign of resuming even after 8 h (Figure 1C). Overexpression
of YoeB toxin, which likely an endoribonuclease as its E. coli
homolog (Christensen et al., 2004; Zhang and Inouye, 2009),
did not result in very obvious differences in morphology when
compared to the wild type (Figures 3A,B).
OTHER TAs IN S. PNEUMONIAE AND THEIR GENETIC ORGANIZATION
The relBE1 operon
A previous study showed that RelE1 of S. pneumoniae had no
RNase activity (Christensen and Gerdes, 2003), but the cell
growth profile after overexpression of RelE1 was not assessed.
Here, we confirmed that expression of RelE1 was not detrimen-
tal to its homologous host or to the heterologous host E. coli
(Figure 1) even though RelE1 shared 52% similarity with RelE2
(in the Hungary19A-6 strain) which had been demonstrated to
be functional (Nieto et al., 2006). In spite of the high conser-
vation of both relB1 and relE1 in all the strains (not shown),
two (R65 and R85) out of five crucial residues responsible for
RelE toxicity in Pyrococcus horikoshii were missing in the pneu-
mococcal RelE1 (Takagi et al., 2005; Nieto et al., 2010; Chan
FIGURE 3 | Morphology of E. coli cells under microscope at 100 ×
magnification after overexpression of the respective pneumococcal
toxins. Morphology of the cells which harbor (A) the negative control
pFUS2SD, (B) the positive control pFUS2SD_YoeB, (C) pFUS2SD_Ant and (D)
pFUS2SD_Bro, were examined after 8 h of overexpression. Filamented cells
were observed in cultures overexpressing Ant or Bro, but no prominent
differences were found for cells overexpressing YoeB when compared to wild
type.
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et al., 2012). In addition, truncation of relE1 in some strains,
such as ATCC 700669 and 70585 was also observed. In gen-
eral, the gene arrangement around the relBE1 genes of all the
strains was similar, i.e., these genes were flanked upstream by
genes that encode DNA polymerase III, elongation factor G and
30s ribosomal proteins, whereas downstream genes were found
to be encoding a possible amino peptidase, an integral membrane
protein and ribosomal small subunit pseudouridine synthase. In
some instances, transposases were identified further upstream of
relB1 (strains ATCC 700669 and INV104). Conservation of the
relBE1 gene pair in many of the pneumococcal genomes could
point to a function not related to type II TA, but this remains to be
investigated.
The gene pairs xreA-ant and bro-xreB
These two gene pairs were previously proposed as putative TAs in
bioinformatics searches of the S. pneumoniae genome (Makarova
et al., 1999; Chan et al., 2012). Overexpression of the pneu-
mococcal Ant and Bro proteins inhibited cell growth in both
S. pneumoniae and E. coli, but co-expression of their putative
respective cognate genes xreA and xreB did not counteract their
toxicity. However, we still do not rule out the possibility that Ant
and Bro are solitary toxins, similar to the MazF-mx of M. xan-
thus, which lacks the co-transcribed antitoxin (Nariya and Inouye,
2008). MrpC, which is expressed from another part of theM. xan-
thus genome, serves as an antitoxin by forming complexes with
MazF-mx, and it also positively regulates theMazF-mx expression
(Nariya and Inouye, 2008).
We made use of a web server designed to identify prophages
(PHAST; Zhou et al., 2011) to search whether pneumococcal
xreA-ant and bro-xreB gene pairs were located within pneu-
mococcal prophages. We found that they are located within
a 94.4 kb intact prophage termed Streptococcus phage MM1
of S. pneumoniae Hungary19A-6 strain (Supplementary mate-
rial). Analysis with Pfam showed that both Ant and Bro have
two domains, respectively: Ant (232 amino acids) has an AntA
(AntA/AntB antirepressor) domain at the N-terminal moiety
and a phage antirepressor KilAC domain at the C-terminal
moiety (Figure 4A); whereas Bro (237 amino acids) has a Bro-
N domain at the N-terminus and an ORF6C (C-terminal of
bacteriophage bIL2850 ORF6) (Iyer et al., 2002) domain at
the C-terminus (Figure 4B). Both KilA and Bro domains are
widely prevalent in bacteriophages, bacteria, eukaryotic viruses
of the nucleo-cytoplasmic large DNA virus and baculovirus
classes (Iyer et al., 2002). A study by Kuan et al. showed that
the protein ANT8 (ORF8) of lytic corynephage P1201 iso-
lated from Corynebacterium glutamicum harbors a Bro domain
at the N-terminus and an antirepressor domain at the C-
terminal end (http://research.nchu.edu.tw/upfiles/ADUpload/oc
downmul2272130635.pdf). In this case, the DNA binding ability
of ANT8 was contributed by the Bro domain, whereas overex-
pression of the antirepressor domain inhibited E. coli cell growth
and also killed the cells as shown by a decrease in colony forming
units. Under microscopic examination, the cells that overex-
pressed the ANT8 protein became filamentous, with irregular
multiple nucleoids, indicating inhibition of cell division, and this
result is also in agreement with our findings.
FIGURE 4 | The domains of pneumococcal Ant and Bro toxins.
Sequence analyses from Pfam showed that (A) pneumococcal Ant harbors
two domains, with the AntA domain at the N-terminus and KilAC domain at
the C-terminus; whereas (B) pneumococcal Bro harbors a Bro-N domain at
the N-terminal and an ORF6C domain at the C-terminal.
GENOMIC CONTEXT OF THE FUNCTIONAL PNEUMOCOCCAL TAs relBE2
AND pezAT, AND THEIR DISTRIBUTION IN S. PNEUMONIAE
POPULATION
The distribution of functional TAs showed a very good correla-
tion with pneumococcal STs and CCs (Table 2). As described in
our previous report, RelBE2 is present in all the 48 pneumococ-
cal database strains with seven out of them having two copies.
Moreover, six different gene organizations were found for this
TA (Chan et al., 2012) that fall into two groups, encompassing
the previously defined Types I-IV and Types V-VI (Chan et al.,
2012; Figure 5A). The latter are flanked by xre upstream and
COG2856B downstream, an arrangement that is not observed
in Types I-IV. RelE2 of Types V and VI were also clustered
together in the phylogenetic analyses (Figure 5B). In addition,
in strains with two copies of RelBE2, one copy belonged to
Types I-IV whereas the second copy belonged to either Type
V or VI. Integrases and IS elements were evident in Types III-
VI. The particular gene arrangement showed also a very good
agreement with STs and CCs, with a single exception in the
Taiwan19F-14 international clone (Table 2). All these observations
suggest that the second copy of relBE2 may likely be horizontally
acquired by some strains rather than represent a product of gene
duplication.
In our previous bioinformatics search, 28 out of the 48 anno-
tated pneumococcal strains harbored a single copy of pezAT;
whereas three strains harbored two copies (Chan et al., 2012).
The two copies of pezAT within the same strain were almost
identical (similarities of 96–97%), and the catalytically impor-
tant residues (Meinhart et al., 2003) were also conserved. The
gene organization of pezAT among the various S. pneumoniae
strains is even more varied than relBE2. This TA is flanked
by a number of genes that contribute to site-specific recombi-
nation and even genes that play roles in conjugative transfer.
The pezAT locus is known to be present on a genomic island
known as the pneumococcal pathogenicity island 1 (Meinhart
et al., 2003; Nieto et al., 2006) but interestingly, a search using
a web-based resource for bacterial ICEs known as ICEberg
database led us to discover the presence of a previously unre-
ported pezAT operon in a putative pneumococcal ICE des-
ignated Tn5253 (Ayoubi et al., 1991). This was corroborated
when a recent analysis of the complete sequence of Tn5253
from S. pneumoniae DP1322 indicated the presence of two
copies of pezAT (Iannelli et al., 2014) which comprised part
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FIGURE 5 | Gene organization and phylogenetic analyses of
pneumococcal RelE2 homologs. (A) Polymorphisms associated with the
gene organization of relBE2 and their neighboring genes found in 48
pneumococcal strains. Six variations of gene organizations were found (Type
I–VI). In general, the relBE2 operon was flanked upstream by vicX
(metal-dependent hydrolase), whereas a RUP (repeat unit of pneumococcus),
element, ldh (lactate dehydrogenease), and gyrA (the A subunit of DNA
gyrase) are located downstream for Type I–IV. For Type V–VI, the relBE2
cassette is flanked upstream by xre-like protein and COG2856B downstream.
Mobile elements are seen in Types III–VI. Other abbreviations used:
restriction-modification (RM); restriction-endonuclease (RE); hypothetical
protein (HP). (B) Phylogenetic analyses of RelE2 homologs with
neighbor-joining algorithm, in which the determined start codon of relE2 was
considered (Moreno-Córdoba et al., 2012), had shown that Type V and Type VI
gene organizations of RelE2 cluster together, indicating RelE2 from both
types are of more similar in sequences. The type of relBE2 gene organization
was indicated. For the strain Canada MDR 19F, the type of gene arrangement
is unknown due to data unavailability in the NCBI databases.
of a 1169 bp direct repeat that flanks the cat(pC194) ele-
ment within Tn5253. Experimental evidence showed that excision
of cat(pC194) from Tn5253 occurred by a recombination
event within the pezAT-containing repeat segment leaving one
copy in Tn5253 and another copy in the newly-excised plasmid
pC194 (Iannelli et al., 2014). Besides that, ectopic integration
of cat(pC194) to other regions of the S. pneumoniae genome
was also detected, likely by homologous recombination involv-
ing the pezAT-containing direct repeat segments (Iannelli et al.,
2014). Thus, pezAT appeared to play a direct role in the trans-
fer of the cat(pC194) element and may also help in the stable
maintenance of this element in its hosts. It is therefore not sur-
prising that phylogenetic analyses showed that PezAT found in
Tn5253 formed a separate cluster from PezAT located in the pneu-
mococcal pathogenicity island 1 (Supplementary Figure S2 and
Table S1).
CONCLUSIONS
Previous searches for putative type II TAs in S. pneumoniae (Chan
et al., 2012, 2013) led us to conclude that their number was greatly
undervalued. However, our present in vivo validation has shown
that, indeed, only four of the TAs, namely RelBE2 (Nieto et al.,
2006), YefM-YoeB (Nieto et al., 2007; Chan et al., 2011), PezAT
(Khoo et al., 2007; Mutschler et al., 2011) and now, Phd-Doc
can be considered as bona fide TAs in the “classical” sense that
the harmful effects of the toxins must be counteracted by their
cognate antitoxins and that their two genes should be organized
as an operon (Gerdes, 2013). Bioinformatics search approaches
have helped us to identify various putative TA homologs; how-
ever, the actual number of bona fide TAs might be overestimated
as in our case e.g., pneumococcal relBE2 is functional TA but
pneumococcal relBE1 is apparently not. In the case of M. tuber-
culosis, of the 88 putative TAs identified, only 30 are functional
(Ramage et al., 2009). Other approaches like shotgun cloning as
presented by Sberro et al. (2013) could be another alternative and
more thorough approach to identify TAs. However, there might
bemore TAs than these four if we consider Ant and Bro as possible
solo toxins whose respective antitoxins might be located else-
where in the pneumococcal chromosome. The finding that these
two novel proteins might be associated with lysogenic bacterio-
phages is, indeed, appealing and merits an in-depth study of their
features.
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